An entirely new approach to obesity, vBloc® Therapy is the only neurometabolic therapy FDA approved to treat obesity.
Have tried to lose weight by diet and exercise in a supervised program within the last 5 years
Are at least 18 years of age
Have a BMI of 35 to 39.9 with a health-related condition such as: type 2 diabetes, high blood pressure, sleep apnea, high cholesterol
BMI of 40 to 45
The device should not be implanted in patients: who have cirrhosis of the liver, portal hypertension, esophageal varices or an uncorrectable, clinically significant hiatal hernia; for whom magnetic resonance imaging (MRI) or shortwave, microwave, or therapeutic ultrasound diathermy is planned; at high risk for surgical complications; or who have an implanted electronic medical device or gastrointestinal device or prosthesis.
With so many patients opting to avoid obesity treatment, it’s obvious there’s a gap between patient need and a practical solution. vBloc Therapy addresses it. It is estimated that over 14 million people in the US are eligible for vBloc Therapy. 2